Daily non-political popular news in brief.
New Jefferson trial to test radiation-emitting beads against advanced liver cancer
02-12-2008 · EurekAlert!Liver cancer specialists at Jefferson's Kimmel Cancer Center in Philadelphia are beginning an 18-month study of a new treatment for liver cancer. The therapy entails injecting tiny beads that emit small amounts of radiation into the liver's main artery while also blocking the blood supply feeding the cancer’s growth.
Read more »
Keywords: jefferson, trial, test, radiation-emitting, beads, advanced, liver, cancer, radiation, emitting, bead
« Previous | Next »
Similar news on "New Jefferson trial to test radiation-emitting beads against advanced liver cancer":
- Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
06-22-2007 · EurekAlert!
A team of researchers, led by surgeons at the Kimmel Cancer Center at Jefferson in Philadelphia, has found further evidence supporting the ability of a protein to predict how well a patient with advanced pancreatic cancer will do after surgery, chemotherapy and radiation.
Similar news · Read more »
- Nexavar shown to significantly extend survival for patients with advanced liver cancer
02-12-2007 · EurekAlert!
Bayer Pharmaceuticals Corp., and Onyx Pharmaceuticals, Inc., today announced that an independent data monitoring committee (DMC) has reviewed the safety and efficacy data from the companies' pivotal Phase 3 trial in patients with advanced hepatocellular carcinoma (HCC), or primary liver cancer.
Similar news · Read more »
- New treatment increases life time expectancy of patients suffering from advanced liver cancer
06-04-2007 · EurekAlert!
A clinical trial led and coordinated by Hospital Clínic-IDIBAPS, using a drug named Sorafenib, revolutionizes the reality of patients suffering from advanced liver cancer. The results increase overall survival of treated patients by 44 percent in comparison to the control group. The results have been hand selected to be included on the "Best of ASCO" program.
Similar news · Read more »
- Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
09-28-2007 · EurekAlert!
An oral presentation covering interim results from a U.K. Phase Ia/Ib combination Reolysin and radiation clinical trial for patients with advanced or metastatic cancers is scheduled to be presented at the National Cancer Research Institute conference on Oct. 2, 2007.
Similar news · Read more »
- Blood test may help signal tumor's remission, return in throat cancer patients
06-01-2007 · EurekAlert!
A blood test that detects proteins commonly released by a growing tumor could one day become a useful tool for monitoring the effectiveness of chemotherapy and radiation treatment in people with advanced throat cancer, according to a study published in the June 1, 2007, issue of Clinical Cancer Research.
Similar news · Read more »
- Jefferson researchers show chemotherapy and radiation together extend lung cancer patients' lives
11-09-2007 · EurekAlert!
Chemotherapy given at the same time as radiation therapy can help patients with a certain type of lung cancer live nearly 50 percent longer than they might have otherwise if the same treatment was given differently, according to an international team’s analysis of several trial results.
Similar news · Read more »
- Jefferson radiation oncologists use real-time system to plant 'seeds' against cancer
09-21-2007 · EurekAlert!
Radiation oncologists and urologists at the Kimmel Cancer Center at Jefferson have begun using a real-time system to implant radiation-emitting seeds in prostate cancer patients. While the system is only being used for imaging and planning so far, it ultimately will help in placing the seeds. The team hopes that the technology will make a good system even better, adding scientific precision to a treatment that currently relies mainly on physician experience and skill.
Similar news · Read more »
- Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
06-04-2007 · EurekAlert!
The number of tumor cells circulating in the bloodstream of patients with metastatic, hormone-resistant, prostate cancer can predict how they will do with chemotherapy, according to results of an international trial. The findings, if backed by larger studies, could have important implications for designing personalized treatments for this very dangerous type of prostate cancer, says a Jefferson Medical College researcher and study first author.
Similar news · Read more »
- UF scientists work to develop simple bladder cancer test
07-05-2007 · EurekAlert!
University of Florida and University of Michigan scientists isolated nearly 200 proteins from the urine of patients with and without bladder cancer. Several appear promising as potential biomarkers, including one that studies conducted elsewhere have already linked to liver and ovarian cancer.
Similar news · Read more »
- Bevacizumab found to improve survival for patients with advanced breast cancer
12-26-2007 · EurekAlert!
Inhibiting the growth of blood vessels that supply tumors slows the progression of metastatic breast cancer according to results of a large clinical trial of Avastin, an antiangiogenic therapy. The study, published in the Dec. 27 issue of the New England Journal of Medicine, found that Avastin in combination with chemotherapy significantly prolongs progression-free survival for women with breast cancer compared to chemotherapy alone.
Similar news · Read more »
